Nephrology studies require nuance and precision, not just execution.
Our teams deliver disciplined operations and transparent oversight — with global experience in rare and chronic renal disorders.
Why Biorasi for Nephrology?
Nephrology trials often involve specialized labs, biopsy-based eligibility, and unique patient pathways. Biorasi delivers oversight and integration across these touchpoints, with real-time reporting dashboards and seasoned leadership guiding every phase.
Subspecialties
- Rare kidney disease
- Chronic Kidney Disease (CKD)
- Acute Kidney Injury (AKI)
- Renal outcomes in obesity and heart failure
- Immunologic and inflammatory renal disease
Proof of
Performance
- 16 Studies
- 10 Indications
- 1,277 Patients Enrolled
Case Studies and Results
- Global C3G Trial (C3 Glomerulopathy)
- 48 patients at 17 sites
- Multiple protocol reviews and revisions
- Over-recruited in a globally dispersed population
- Integrated medical monitoring and vendor coordination ensured trial stability
FROM OUR PARTNERS
Professor Bertil E. Lindmark
MD, PhD, CMO,, Biotech Leader
“In addition to hitting their recruitment target, Biorasi brought fresh energy to our trial. Their involvement helped motivate our incumbent CRO to raise their performance and accelerated execution across the entire study team.”